CLINICAL_TRIALS
trial_result
· 2024-08-12
Clinical Trial Update: Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus [Phase 1]
Summary
Phase 1 trial of multiple oral doses of PF-07081532 in adults with Type 2 Diabetes Mellitus completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2024-08-12